Schedule of Warrant Activity (Details) - Warrant [Member] - USD ($) |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2023 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Number of warrants, outstanding, beginning balance | 25,684,521 | ||
| Weighted average remaining contractual life in years | 11 months 4 days | ||
| Aggregate intrinsic value, balance | $ 24,000 | ||
| Number of warrants, granted | |||
| Number of warrants, forfeited or expired | 25,684,521 | ||
| Number of warrants, outstanding, ending balance | |||
| Weighted average exercise price, outstanding, ending balance | $ 0.0247 | ||
| Number of warrants, exercisable | |||
| Weighted average exercise price, exercisable |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-option equity instruments exercisable. No definition available.
|
| X | ||||||||||
- Definition Share based payment, non option outstanding weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based payment, warrants outstanding weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based payment, warrants instrinsic value. No definition available.
|
| X | ||||||||||
- Definition Share based payment, warrants remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|